Showing results (901-910 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|May 21, 2016
Activity of aldehyde dehydrogenase in B-cell and plasma cell subsets of monoclonal gammopathy patients and healthy donorsPavla Všianská, Renata Bezděková, Fedor Kryukov, et al.
European Journal of Haematology|May 28, 2016
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre studyNicolás Martínez-Calle, Ana Alfonso, José Rifón, et al.
European Journal of Haematology|April 28, 2016
Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation settingBelén Blanco, María Del Carmen Herrero-Sánchez, Concepción Rodríguez-Serrano, et al.
European Journal of Haematology|April 29, 2016
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)Antonio Girolami, Elisabetta Cosi, Claudia Santarossa, et al.
European Journal of Haematology|June 9, 2016
The first Team Haemophilia Education meeting, 2015, Amsterdam, The NetherlandsErik Berntorp, Daniel Hart, Maria Elisa Mancuso, et al.
European Journal of Haematology|June 2, 2016
Factors associated with the effect of open splenectomy for immune thrombocytopenic purpuraYing Li, Dawei Zhang, Fanli Hua, et al.
European Journal of Haematology|January 1, 1989
Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemiaC Melani, L Canepa, M Sessarego, et al.
European Journal of Haematology|January 1, 1989
A myelokathexis-like variant of myelodysplasiaS M Rassam, P Roderick, I al-Hakim, et al.
European Journal of Haematology|December 12, 2017
Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patientsCharlotte Gran, Gösta Gahrton, Evren Alici, et al.
European Journal of Haematology|December 12, 2017
Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemiaLuis Felipe Casado, José Ángel Hernández, Isidro Jarque, et al.
Pageof 527